Editas Medicine, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $40.5 | $32.3 | $78.1 | $19.7 | $25.5 |
| Operating income | -$160.0 | -$251.2 | -$169.2 | -$225.9 | -$193.1 |
| Net income | -$160.1 | -$237.1 | -$153.2 | -$220.4 | -$192.5 |
| Cash Flow Statement | |||||
| Free cash flow | -$165.8 | -$219.1 | -$136.9 | -$181.5 | -$171.8 |
Shares outstanding 97.9M · Free float 93.3%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.